Drug Profile
SPI 3608
Alternative Names: SPI-3608Latest Information Update: 21 Feb 2018
Price :
$50
*
At a glance
- Originator Sucampo Pharmaceuticals
- Class Fatty acids
- Mechanism of Action Chloride channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Spinal stenosis